| 1656851
|
Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14. |
Antimicrob Agents Chemother |
1991 |
Fox MP;McKinlay MA;Diana GD;Dutko FJ |
View
More |
| 1666824
|
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. |
Antiviral Res |
1991 |
Andries K;Dewindt B;Snoeks J;Willebrords R;Stokbroekx R;Lewi PJ |
View
More |
| 3018924
|
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. |
Science |
1986 |
Smith TJ;Kremer MJ;Luo M;Vriend G;Arnold E;Kamer G;Rossmann MG;McKinlay MA;Diana GD;Otto MJ |
View
More |
| 7473717
|
Structural studies on human rhinovirus 14 drug-resistant compensation mutants. |
J Mol Biol |
1995 |
Hadfield AT;Oliveira MA;Kim KH;Minor I;Kremer MJ;Heinz BA;Shepard D;Pevear DC;Rueckert RR;Rossmann MG |
View
More |
| 7811059
|
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses. |
Antiviral Res |
1994 |
Dewindt B;van Eemeren K;Andries K |
View
More |
| 8391247
|
SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. |
Antiviral Res |
1993 |
Rozhon E;Cox S;Buontempo P;O'Connell J;Slater W;De Martino J;Schwartz J;Miller G;Arnold E;Zhang A;et al. |
View
More |
